{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:49:14Z","timestamp":1792727354441,"version":"4.5.0"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T00:00:00Z","timestamp":1135036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:p><jats:bold>Background and Objectives\u2002<\/jats:bold><jats:italic>Leishmania<\/jats:italic>is transmitted by the bite of the phlebotomine sandfly or by transfusion of infected blood products. Leishmaniasis currently poses a significant problem in several parts of the world, and is an emerging problem in others. The Mirasol PRT technology is based on the use of riboflavin and ultraviolet light to generate chemical reactions in the nucleic acids of pathogens, which prevents replication and leads to inactivation. The intent of this study was to examine the ability of the Mirasol PRT System to kill the<jats:italic>Leishmania<\/jats:italic>parasite in human plasma and platelet concentrates.<\/jats:p><jats:p><jats:bold>Materials and Methods\u2002<\/jats:bold>In visceral Leishmaniasis, amastigotes are present in the blood and in the reticuloendothelial system within monocytes. For each unit of plasma or platelets treated, isolated mononuclear cells obtained from 100\u00a0ml of normal donor whole blood were incubated with 1\u00b70\u00a0\u00d7\u00a010<jats:sup>8<\/jats:sup><jats:italic>Leishmania donovani infantum<\/jats:italic>promastigotes to produce amastigote\u2010laden macrophages. The infected macrophages were added to 250\u00a0ml of human plasma or to 250\u00a0ml of platelet concentrates. Infected units were cultured pretreatment in 10\u2010fold serial dilutions to determine the limits of detection. Thirty millilitres of 500\u00a0\u00b5<jats:sc>m<\/jats:sc>riboflavin was added to each unit, which was then illuminated with 5\u00b79\u00a0J\/cm<jats:sup>2<\/jats:sup>of ultraviolet light (6\u00b724\u00a0J\/ml). After treatment and after 2\u00a0months of frozen storage, plasma units were cultured in 10\u2010fold serial dilutions. Platelets were cultured on the day of treatment and on day\u00a05 of storage post\u2010illumination.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>A 5 log reduction of<jats:italic>Leishmania<\/jats:italic>was demonstrated in five of six units of plasma, and a 7 log reduction of<jats:italic>Leishmania<\/jats:italic>was demonstrated in one plasma unit. A 5 log reduction of<jats:italic>Leishmania<\/jats:italic>was demonstrated in five of six units of platelets, and a 6 log reduction of<jats:italic>Leishmania<\/jats:italic>was demonstrated in one unit.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold>There is no donor screen for<jats:italic>Leishmania<\/jats:italic>and other pathogens constantly emerging in our blood supply. The Mirasol PRT System for Platelets and Plasma is an effective means of killing<jats:italic>Leishmania<\/jats:italic>and other emerging pathogens in these blood products.<\/jats:p>","DOI":"10.1111\/j.1423-0410.2005.00736.x","type":"journal-article","created":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T14:34:46Z","timestamp":1135089286000},"page":"85-91","source":"Crossref","is-referenced-by-count":89,"title":["Pathogen inactivation of<i>Leishmania donovani infantum<\/i>in plasma and platelet concentrates using riboflavin and ultraviolet light"],"prefix":"10.1111","volume":"90","author":[{"given":"L. J.","family":"Cardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"Rentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ketchum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Salata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Harman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Melvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Weina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7264.801"},{"key":"e_1_2_6_3_2","first-page":"325","article-title":"The first two cases of transfusion kala\u2010azar","volume":"66","author":"Chung HL","year":"1948","journal-title":"Chin Med J"},{"key":"e_1_2_6_4_2","first-page":"379","article-title":"Cutaneous leishmaniasis, cutaneous glandular leishmaniasis and transfusional kala\u2010azar","volume":"55","author":"Andre R","year":"1958","journal-title":"Trop Dis Bull"},{"key":"e_1_2_6_5_2","first-page":"384","volume-title":"Proceedings of the Seventh International Congress of Tropical Medicine and Malaria.","author":"Kostmann R","year":"1963"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90129-D"},{"key":"e_1_2_6_7_2","first-page":"237","article-title":"Viceral leishmaniasis in an infant in Brittany: discussion on the modes of transmission outside of the endemic zone","volume":"48","author":"Mauny I","year":"1993","journal-title":"Pediatrie"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.72.3.235"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36996420769.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0958-7578.2004.00520.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1993.49.308"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(01)00150-4"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00061.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2001.219.1076"},{"key":"e_1_2_6_15_2","first-page":"1311","article-title":"Transmission of visceral leishmaniasis by blood transfusion in hamsters","volume":"29","author":"Palatnik\u2010de\u2010Sousa CB","year":"1996","journal-title":"Braz J Med Biol Res"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/JCM.37.6.1953-1957.1999","article-title":"Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France","volume":"37","author":"Fichoux Y","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.6.1003"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.1.1"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.001055"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10178-2"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/63.1.54"},{"key":"e_1_2_6_22_2","first-page":"75","article-title":"Studies on the toxicity and pharmacology of riboflavin","volume":"75","author":"Unna K","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_23_2","first-page":"186","article-title":"Ultraviolet radiation\u2010induced photodegradation and 1O2, O2 \u2212 production by riboflavin, lumichrome and lumiflavin","volume":"26","author":"Joshi PC","year":"1989","journal-title":"Indian J Biochem Biophys"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1423-0410.2000.tb00065.x","article-title":"The use of riboflavin for the inactivation of pathogens in blood products","volume":"78","author":"Goodrich RP","year":"2000","journal-title":"Vox Sang"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03355.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04350.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00202.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2004.00548.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04381.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1980.29.199"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0907.030023"},{"key":"e_1_2_6_32_2","first-page":"265","article-title":"Two cases of visceral leishmaniasis in U.S. military personnel \u2013 Afghanistan","volume":"53","author":"Morbidity and Mortality Weekly Report","year":"2004","journal-title":"MMWR"},{"key":"e_1_2_6_33_2","first-page":"264","volume":"53","author":"Morbidity and Mortality Weekly Report","year":"2004","journal-title":"Update"},{"key":"e_1_2_6_34_2","first-page":"131","article-title":"Viscerotropic Leishmaniasis in Persons Returning from Operation Desert Storm \u2013 1990\u20131991","volume":"41","author":"Morbidity and Mortality Weekly Report","year":"1992","journal-title":"MMWR"},{"key":"e_1_2_6_35_2","volume-title":"AABB Association Bulletin #03:14.","author":"AABB","year":"2003"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305133281904"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90446-L"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199212000-00013"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2005.00736.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.2005.00736.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:02:50Z","timestamp":1736182970000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2005.00736.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,20]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1111\/j.1423-0410.2005.00736.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2005.00736.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,20]]}}}